EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genetic suppressors as new therapeutic targets for Mendelian diseases

Claire Paltenghi-Peceva, Sabine van Schie, Erfan Heidari, Stephen Friend, Jolanda van Leeuwen

Trends in Genetics · 2026-10 · 42 (10) · 888-897

DOI: 10.1016/j.tig.2026.06.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Genetics, 2026-10. Verfasst von Claire Paltenghi-Peceva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Integrative Genomics, University of Lausanne, Lausanne CH-1015, Switzerland. Hauptthemen laut MEDLINE: Genetic Diseases, Inborn, Genetic Predisposition to Disease, Suppression, Genetic. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most Mendelian diseases lack effective treatments, with current options often limited to symptomatic care rather than addressing the underlying genetic defect. In this opinion article, we argue that genetic suppressors, a specific class of modifier variants that can counteract the effects of disease-causing mutations, can identify promising new avenues for therapeutic intervention. We discuss the prevalence of potential suppressors across Mendelian diseases, describe approaches for their systematic identification, and consider their therapeutic relevance. As genome-wide screening technologies and machine learning methods continue to advance, we expect suppressor identification to accelerate in the near future. These suppressors present exciting opportunities for expanding our therapeutic arsenal and improving outcomes for individuals with inherited disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Diseases, InbornGenetic Predisposition to DiseaseSuppression, GeneticHumansMutationAnimalsGenome-Wide Association StudyGenes, Modifier

Stichwörter der Autor:innen

genetic resiliencegenetic suppressionmodifier genesprotective modifiers

Autor:innen und Institutionen

  • Center for Integrative Genomics, University of Lausanne, Lausanne CH-1015, Switzerland.
  • Center for Integrative Genomics, University of Lausanne, Lausanne CH-1015, Switzerland; Department of Systems Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
  • 4YouandMe, Great Neck, NY 11021, USA; Department of Psychiatry, Oxford University, Oxford OX3 7JX, UK.
  • Center for Integrative Genomics, University of Lausanne, Lausanne CH-1015, Switzerland; Department of Systems Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Electronic address: jolan…

Zitieren

APA

Paltenghi-Peceva, C., van Schie, S., Heidari, E., Friend, S., & van Leeuwen, J. (2026). Genetic suppressors as new therapeutic targets for Mendelian diseases. Trends in Genetics, 42(10), 888-897. https://doi.org/10.1016/j.tig.2026.06.003

Vancouver

Paltenghi-Peceva C, van Schie S, Heidari E, Friend S, van Leeuwen J. Genetic suppressors as new therapeutic targets for Mendelian diseases. Trends in Genetics. 2026;42(10):888-897. doi:10.1016/j.tig.2026.06.003

BibTeX
@article{PaltenghiPeceva2026,
  author = {Paltenghi-Peceva, Claire and van Schie, Sabine and Heidari, Erfan and Friend, Stephen and van Leeuwen, Jolanda},
  title = {Genetic suppressors as new therapeutic targets for Mendelian diseases},
  journal = {Trends in Genetics},
  year = {2026},
  volume = {42},
  number = {10},
  pages = {888--897},
  doi = {10.1016/j.tig.2026.06.003}
}
Kostenlos starten →